Research & Development



  甦稚冷笑道︰“別以為妾身沒有用處,大秦嶺里妾身還是做了一些準備的。只要我願意,疫病在關中流行開來不算什麼難事。”   “某家听說周鴻作亂之後,陛下再一次削減了勛貴大臣們的部曲?雲氏可曾受災?”来射吧AV在线播放视频   張安世點頭道︰“知道了,最大的一筆金錢是支付給城衛軍金日處的。我想,這筆錢陛下應該是不會追問的。”caoporn超碰在线视频   “皇帝知道我們家的厲害,他不敢拿為我們怎麼樣是吧?”   霍光笑道︰“您第一次毆打我的時候就說了,這世上的人以力為尊,您的力氣大,可以心安理得的揍我,還說,等有一天我的武力超過您了,就不用對您畢恭畢敬了。”水莓100视频来射吧AV在线播放视频   關中是世界上最富庶的地方,這些人對于搶劫關中百姓的興趣,遠比幫劉據實現登上皇位要重要的多。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo